RCC2 Expression Stimulates ER-Positive Breast Tumorigenesis.

Area of Science:

• Molecular biology
• Oncology
• Cell biology

Background:

• Regulator of chromosome condensation 2 (RCC2) is implicated in cell cleavage regulation.
• Estrogen receptor-positive (ER+) breast cancer is a significant health concern.
• The specific role of RCC2 in breast tumorigenesis requires further investigation.

Purpose of the Study:

• To investigate the effect of Regulator of chromosome condensation 2 (RCC2) expression on breast tumorigenesis.
• To elucidate the molecular mechanisms by which RCC2 influences ER+ breast cancer development.
• To explore the interplay between estrogen, RCC2, and tumor-promoting pathways.

Main Methods:

• MCF-7 cells (ER+ breast cancer) were manipulated for RCC2 expression (siRNA, plasmids).
• Cellular functions including proliferation, apoptosis, and migration were assessed.
• Tumorigenic pathways were analyzed using PCR arrays and in vivo mouse models (MRI).

Main Results:

• RCC2 expression was elevated in ER+ breast tumors.
• RCC2 inhibition decreased migration and increased apoptosis; RCC2 overexpression had opposite effects.
• Inhibition of RCC2 reduced tumor growth, IL-6, IGF1, and TWIST1 levels in vivo and in vitro.
• Estrogen upregulated RCC2, IGF1, and TWIST1, and suppressed apoptosis, effects partially mediated by RCC2.

Conclusions:

• Estrogen-induced RCC2 expression contributes to ER+ breast tumorigenesis.
• RCC2 promotes tumor growth by upregulating IGF1, TWIST1, and IL-6.
• RCC2 stimulates cell migration and inhibits apoptosis, key processes in cancer progression.